Catalent, Inc.

CTLTNYSEHealthcare

$63.48

+$0.00(+0.00%)

Market Cap$11.5B

P/E Ratio—

52W High$63.5

52W Low$42.11

Avg Volume2.2M

Open$63.49

Beta1.16

Insider Trades Ownership Employees

Catalent, Inc. (CTLT) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · CTLT · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Catalent, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

CTLT insider buying and selling by quarter

CTLT insider selling · CTLT insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

1.1M549K0

2023 Q1

2023 Q2

2023 Q3

2023 Q4

2024 Q1

2024 Q2

2024 Q3

2024 Q4

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

CTLT executive sell shares · CTLT board member insider trading · CTLT insider trading SEC filing

Showing 76 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Dec 18, 2024	Gennadios Aristippos Group Pres. Pharma & Consumer	Award	21,562	—	—	21,562	Form 4
Dec 18, 2024	Gennadios Aristippos Group Pres. Pharma & Consumer	Other	21,562	—	—	0	Form 4
Dec 18, 2024	McErlane David Group President, Biologics	Award	11,426	—	—	11,426	Form 4
Dec 18, 2024	McErlane David Group President, Biologics	Other	11,426	—	—	0	Form 4
Dec 18, 2024	Hatzfeld Michael CAO	Award	3,144	—	—	3,144	Form 4
Dec 18, 2024	Hatzfeld Michael CAO	Other	3,144	—	—	0	Form 4
Dec 18, 2024	Gunther Scott SVP, Quality & Reg. Affairs	Award	12,938	—	—	12,938	Form 4
Dec 18, 2024	Gunther Scott SVP, Quality & Reg. Affairs	Other	12,938	—	—	0	Form 4
Dec 18, 2024	Ferraro Joseph Anthony SVP, General Counsel, CCO	Award	14,265	—	—	14,265	Form 4
Dec 18, 2024	Ferraro Joseph Anthony SVP, General Counsel, CCO	Other	14,265	—	—	0	Form 4
Dec 18, 2024	STAHL JACK L Director	Other	47,984	—	—	0	Form 4
Dec 18, 2024	Ryan Michelle R Director	Other	10,835	—	—	0	Form 4
Dec 18, 2024	Okey Stephanie Director	Other	12,635	—	—	0	Form 4
Dec 18, 2024	MOREL DONALD E JR Director	Other	70,118	—	—	0	Form 4
Dec 18, 2024	LUCIER GREGORY T Director	Other	36,914	—	—	0	Form 4
Dec 18, 2024	DAMELIO FRANK A Director	Other	12,635	—	—	0	Form 4
Dec 18, 2024	CLASSON ROLF A Director	Other	47,984	—	—	0	Form 4
Dec 18, 2024	CARROLL J MARTIN Director	Other	32,734	—	—	0	Form 4
Dec 18, 2024	Barg Steven Director	Other	12,374	—	—	0	Form 4
Dec 18, 2024	Barber Michael J Director	Other	18,052	—	—	0	Form 4
Dec 18, 2024	Maselli Alessandro President & CEO · Director	Award	113,224	—	—	113,224	Form 4
Dec 18, 2024	Maselli Alessandro President & CEO · Director	Other	113,224	—	—	0	Form 4
Dec 18, 2024	Hopson Ricky Pres. BioProduct Delivery, CoS	Award	10,722	—	—	10,722	Form 4
Dec 18, 2024	Hopson Ricky Pres. BioProduct Delivery, CoS	Other	10,722	—	—	0	Form 4
Dec 18, 2024	Masanovich Matti SVP, Chief Financial Officer	Award	71,691	—	—	71,691	Form 4

Gennadios Aristippos

Group Pres. Pharma & Consumer

Award

Date

Dec 18

21,562

Price

—

Value

—

View Form 4 on SEC.gov

Gennadios Aristippos

Group Pres. Pharma & Consumer

Other

Date

Dec 18

21,562

Price

—

Value

—

View Form 4 on SEC.gov

McErlane David

Group President, Biologics

Award

Date

Dec 18

11,426

Price

—

Value

—

View Form 4 on SEC.gov

McErlane David

Group President, Biologics

Other

Date

Dec 18

11,426

Price

—

Value

—

View Form 4 on SEC.gov

Hatzfeld Michael

CAO

Award

Date

Dec 18

3,144

Price

—

Value

—

View Form 4 on SEC.gov

Hatzfeld Michael

CAO

Other

Date

Dec 18

3,144

Price

—

Value

—

View Form 4 on SEC.gov

Gunther Scott

SVP, Quality & Reg. Affairs

Award

Date

Dec 18

12,938

Price

—

Value

—

View Form 4 on SEC.gov

Gunther Scott

SVP, Quality & Reg. Affairs

Other

Date

Dec 18

12,938

Price

—

Value

—

View Form 4 on SEC.gov

Ferraro Joseph Anthony

SVP, General Counsel, CCO

Award

Date

Dec 18

14,265

Price

—

Value

—

View Form 4 on SEC.gov

Ferraro Joseph Anthony

SVP, General Counsel, CCO

Other

Date

Dec 18

14,265

Price

—

Value

—

View Form 4 on SEC.gov

STAHL JACK L

Director

Other

Date

Dec 18

47,984

Price

—

Value

—

View Form 4 on SEC.gov

Ryan Michelle R

Director

Other

Date

Dec 18

10,835

Price

—

Value

—

View Form 4 on SEC.gov

Okey Stephanie

Director

Other

Date

Dec 18

12,635

Price

—

Value

—

View Form 4 on SEC.gov

MOREL DONALD E JR

Director

Other

Date

Dec 18

70,118

Price

—

Value

—

View Form 4 on SEC.gov

LUCIER GREGORY T

Director

Other

Date

Dec 18

36,914

Price

—

Value

—

View Form 4 on SEC.gov

DAMELIO FRANK A

Director

Other

Date

Dec 18

12,635

Price

—

Value

—

View Form 4 on SEC.gov

CLASSON ROLF A

Director

Other

Date

Dec 18

47,984

Price

—

Value

—

View Form 4 on SEC.gov

CARROLL J MARTIN

Director

Other

Date

Dec 18

32,734

Price

—

Value

—

View Form 4 on SEC.gov

Barg Steven

Director

Other

Date

Dec 18

12,374

Price

—

Value

—

View Form 4 on SEC.gov

Barber Michael J

Director

Other

Date

Dec 18

18,052

Price

—

Value

—

View Form 4 on SEC.gov

Maselli Alessandro

President & CEO · Director

Award

Date

Dec 18

113,224

Price

—

Value

—

View Form 4 on SEC.gov

Maselli Alessandro

President & CEO · Director

Other

Date

Dec 18

113,224

Price

—

Value

—

View Form 4 on SEC.gov

Hopson Ricky

Pres. BioProduct Delivery, CoS

Award

Date

Dec 18

10,722

Price

—

Value

—

View Form 4 on SEC.gov

Hopson Ricky

Pres. BioProduct Delivery, CoS

Other

Date

Dec 18

10,722

Price

—

Value

—

View Form 4 on SEC.gov

Masanovich Matti

SVP, Chief Financial Officer

Award

Date

Dec 18

71,691

Price

—

Value

—

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About CTLT insider trading

CTLT insider trades

Catalent, Inc. (CTLT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CTLT. Over the past 12 months, 0 insiders have filed transactions with the SEC. CTLT insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Catalent, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

CTLT insider trading · 5 questions

The insiders of Catalent, Inc. (CTLT) include executives and directors such as CTLT, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

CTLT board member insider tradingwho are CTLT insidersCTLT insider rosterCatalent, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026